Medical foods: Products for the management of chronic diseases

Nutrition Reviews

Volumn 64, Issue 11, 2006, Pages 495-501

  Morgan, Sarah L ^a,b,c   Baggott, Joseph E ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Dietary supplements; Generally recognized as safe (GRAS); Medical foods; Nutritional management

Indexed keywords

BCAD 2; CEREFOLIN; CONISON; FOLGARD; FOLIC ACID; ISOSOURCE; LIMBREL; LOFENALAC; NATURAL PRODUCT; OXEPA; PANCRELIPASE; RENAX; RESOURCE SUPPORT; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; CACHEXIA; CALORIC RESTRICTION; CHRONIC DISEASE; CHRONIC PANCREATITIS; COGNITIVE DEFECT; CYSTIC FIBROSIS; DIET SUPPLEMENTATION; DIET THERAPY; DRUG FORMULATION; ENTERIC COATED TABLET; FOOD AND DRUG ADMINISTRATION; FOOD COMPOSITION; FOOD INTAKE; HEALTH INSURANCE; HUMAN; HYPERHOMOCYSTEINEMIA; INBORN ERROR OF METABOLISM; INFLAMMATION; KIDNEY FAILURE; LUNG INJURY; MAPLE SYRUP URINE DISEASE; MEDICAL PRACTICE ACT; MEGALOBLASTIC ANEMIA; MULTIINFARCT DEMENTIA; OSTEOARTHRITIS; PANCREAS INSUFFICIENCY; PERNICIOUS ANEMIA; PHENYLKETONURIA; PNEUMONIA; PRESCRIPTION; SEPSIS; STEATORRHEA; TUBE FEEDING; ULCER; WOUND HEALING;

CHRONIC DISEASE; DIETARY SUPPLEMENTS; FORECASTING; HEALTH FOOD; HUMANS; LEGISLATION, FOOD; UNITED STATES;

EID: 33751334809     PISSN: 00296643     EISSN: 00296643     Source Type: Journal    
DOI: 10.1301/nr.2006.nov.495-501     Document Type: Article

References (26)

1. Mueller C. The regulatory status of medical foods and dietary supplements in the United States. Nutrition. 1999;15(3):249-251.
2. National Archives & Records Administration. Federal Register 6. November 22, 1941.
3. National Archives & Records Administration. Federal Register 37. September 8, 1972.
4. US Congress. 100th Congress Orphan Drug Act Amendment; 1988.
5. FDA Nutrition & Labeling Act of 1990, Final Amendments. Vol 21 USC 343(q)(5)(A)(iv); 1990.
6. FDA. Enforcement Report. Rockville, MD; July 28, 1993.
7. Medical Foods. FDA Center for Food Safety and Applied Nutrition; 1997.
8. National Archives & Records Administration. Federal Register 61. November 29, 1996.
9. FDA. Health Hazard Evaluation No. 1470. Washington, DC: Center for Food Safety & Applied Nutrition; 1986.
10. FDA. Enforcement Report. Rockville, MD; August 23 1989.
11. Talbot JM. Guidelines for the scientific review of enteral food products for special medical purposes: Prepared by the Life Sciences Research Office, Federation of American Societies for Experimental Biology, Bethesda, MD, for the Food and Drug Administration; 1990.
12. Tice JA, Ross E, Coxson PG, et al. Cost-effectiveness of vitamin therapy to lower plasma homocysteine levels for the prevention of coronary heart disease; effect of grain fortification and beyond. JAMA. 2001;286:936-943.
13. Sundstrom J, Sullivan L, Selhub J, et al.; Framington Heart Study. Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study. Eur Heart J. 2004;25:523-530.
14. Vasan RS, Beiser A, D'Agostino RB, et al. Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction. JAMA. 2003;289:1251-1257.
15. Kark JD, Sinnreich R, Rosenberg IH, Jacques PF, Selhub J. Plasma homocysteine and parental myocardial infarction in young adults in Jerusalem. Circulation. 2002;105:2725-2729.
16. Morgan SL, Baggott JE, Vaughn WH, et al. The effect of folic acid supplementation on the toxicity of low-dose methotrexate treatment of rheumatoid arthritis. Arthritis Rheum. 1990;33:9-18.
17. Morgan SL, Baggott JE, Vaughn WH, et al. Supplementation with folic acid during methotrexate therapy of rheumatoid arthritis: results from a double-blind, placebo-controlled trial. Ann Intern Med. 1994;121:833-841.
18. Botha A, Witkowski ETF, Shackleton CM. A comparison of anthropogenic and elephant disturbance on Acacia xanthophloea (fever tree) populations in the Lowveld, South Africa. Koedoe. 2002;45:9-18.
19. Ahmad MSM, Ahmad A. Chemistry of the Medicinal Plants of Genus Acacia. Hamdard Medicus. 1998;41:63-67.
20. Shao ZH, Li CQ, Vanden Hoek TL, et al. Extract from Scutellaria baicalensis Georgi attenuates oxidant stress in cardiomyocytes. J Mol Cell Cardiol. 1999;31:1885-1895.
21. Nan JX, Park EJ, Kim YC, Ko G, Sohn DH. Scutellaria baicalensis inhibits liver fibrosis induced by bile duct ligation or carbon tetrachloride in rats. J Pharm Pharmacol. 2002;54:555-563.
22. Chi YS, Cheon BS, Kim HP. Effect of wogonin, a plant flavone from Scutellaria radix, on the suppression of cyclooxygenase-2 and the induction of inducible nitric oxide synthetase in lipopolysaccharide-treated RAW 264.7 cells. Biochem Pharmacol. 2001;61:1195-1203.
23. Lin CC, Shieh DE. The anti-inflammatory activity of Scutellaria rivularis extracts and its active components, baicalin, baicalein and wogonin. Am J Chin Med. 1996;24:31-36.
24. Dafallah AA, Al-Mustafa Z. Investigation of the antiinflammatory activity of Acacia nilotica and Hibiscus sabdariffa. Am J Chin Med. 1996;24:263-269.
25. Al-Mustafa ZH, Dafallah AA. A study on the toxicology of Acacia nilotica. Am J Chin Med. 2000;28:123-129.
26. Gao Z, Huang K, Yang X, Xu H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi. Bichim Biophys Acta. 1999;1472:643-650.